BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 33171407)

  • 1. Platinum(IV) complexes conjugated with chalcone analogs as dual targeting anticancer agents: In vitro and in vivo studies.
    Huang X; Liu Z; Wang M; Yin X; Wang Y; Dai L; Wang H
    Bioorg Chem; 2020 Dec; 105():104430. PubMed ID: 33171407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Niacin-ligated platinum(iv)-ruthenium(ii) chimeric complexes synergistically suppress tumor metastasis and growth with potentially reduced toxicity in vivo.
    Shu L; Ren L; Wang Y; Fang T; Ye Z; Han W; Chen C; Wang H
    Chem Commun (Camb); 2020 Mar; 56(20):3069-3072. PubMed ID: 32049075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platinum(IV) complexes conjugated with phenstatin analogue as inhibitors of microtubule polymerization and reverser of multidrug resistance.
    Huang X; Huang R; Gou S; Wang Z; Liao Z; Wang H
    Bioorg Med Chem; 2017 Sep; 25(17):4686-4700. PubMed ID: 28728896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting RAS-RAF pathway significantly improves antitumor activity of Rigosertib-derived platinum(IV) complexes and overcomes cisplatin resistance.
    Liu Z; Wang M; Wang H; Fang L; Gou S
    Eur J Med Chem; 2020 May; 194():112269. PubMed ID: 32248002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo antiproliferative activity on lung cancer of two acylhydrazone based zinc(II) complexes.
    Chang Q; Xie Y; Lu X; Zong Z; Zhang E; Cao S; Liang L
    Bioorg Chem; 2024 Jun; 147():107422. PubMed ID: 38705106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.
    Ma L; Lin X; Li C; Xu Z; Chan CY; Tse MK; Shi P; Zhu G
    Inorg Chem; 2018 Mar; 57(5):2917-2924. PubMed ID: 29436828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Pt(IV) complexes containing salvigenin ligand reverse cisplatin-induced resistance by inhibiting Rap1b-mediated cancer cell stemness in esophageal squamous cell carcinoma treatments.
    Zhao J; Wu K; Yang Y; Liu D; Zhang C; Li X
    Bioorg Chem; 2024 Jun; 147():107384. PubMed ID: 38643568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Square planar Au(III), Pt(II) and Cu(II) complexes with quinoline-substituted 2,2':6',2″-terpyridine ligands: From in vitro to in vivo biological properties.
    Choroba K; Machura B; Szlapa-Kula A; Malecki JG; Raposo L; Roma-Rodrigues C; Cordeiro S; Baptista PV; Fernandes AR
    Eur J Med Chem; 2021 Jun; 218():113404. PubMed ID: 33823390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of anticancer effect in vitro and in vivo of iridium(III) complexes on gastric carcinoma SGC-7901 cells.
    Zhang WY; Wang YJ; Du F; He M; Gu YY; Bai L; Yang LL; Liu YJ
    Eur J Med Chem; 2019 Sep; 178():401-416. PubMed ID: 31202128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pt(IV) complexes conjugating with chalcone analogue as inhibitors of microtubule polymerization exhibited selective inhibition in human cancer cells.
    Huang X; Huang R; Wang Z; Li L; Gou S; Liao Z; Wang H
    Eur J Med Chem; 2018 Feb; 146():435-450. PubMed ID: 29407969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules.
    Savić A; Marzo T; Scaletti F; Massai L; Bartoli G; Hoogenboom R; Messori L; Van Deun R; Van Hecke K
    Biometals; 2019 Feb; 32(1):33-47. PubMed ID: 30367340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization and anticancer activity in vitro and in vivo evaluation of an iridium (III) polypyridyl complex.
    Yi QY; Wan D; Tang B; Wang YJ; Zhang WY; Du F; He M; Liu YJ
    Eur J Med Chem; 2018 Feb; 145():338-349. PubMed ID: 29331805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.
    Wang G; Li C; He L; Lei K; Wang F; Pu Y; Yang Z; Cao D; Ma L; Chen J; Sang Y; Liang X; Xiang M; Peng A; Wei Y; Chen L
    Bioorg Med Chem; 2014 Apr; 22(7):2060-79. PubMed ID: 24629450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes-loaded liposomes as drug delivery system.
    Zhang WY; Du F; He M; Bai L; Gu YY; Yang LL; Liu YJ
    Eur J Med Chem; 2019 Sep; 178():390-400. PubMed ID: 31202127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo anti-glioma activity of a chalcone-quinoxaline hybrid.
    Loch-Neckel G; Bicca MA; Leal PC; Mascarello A; Siqueira JM; Calixto JB
    Eur J Med Chem; 2015 Jan; 90():93-100. PubMed ID: 25461314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nuclear permeable Ru(ii)-based photoactivated chemotherapeutic agent towards a series of cancer cells: in vitro and in vivo studies.
    Tian N; Feng Y; Sun W; Lu J; Lu S; Yao Y; Li C; Wang X; Zhou Q
    Dalton Trans; 2019 May; 48(19):6492-6500. PubMed ID: 30994660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity.
    Tan MX; Wang ZF; Qin QP; Zou BQ; Liang H
    Dalton Trans; 2020 Feb; 49(5):1613-1619. PubMed ID: 31942585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New bio-sensitive and biologically active single crystal of pyrimidine scaffold ligand and its gold and platinum complexes: DFT, antimicrobial, antioxidant, DNA interaction, molecular docking with DNA/BSA and anticancer studies.
    Sankarganesh M; Dhaveethu Raja J; Sakthikumar K; Solomon RV; Rajesh J; Athimoolam S; Vijayakumar V
    Bioorg Chem; 2018 Dec; 81():144-156. PubMed ID: 30121002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of pyridine-chalcone derivatives as novel microtubule-destabilizing agents.
    Xu F; Li W; Shuai W; Yang L; Bi Y; Ma C; Yao H; Xu S; Zhu Z; Xu J
    Eur J Med Chem; 2019 Jul; 173():1-14. PubMed ID: 30981112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical Anticancer Activity of an Electron-Deficient Organoruthenium(II) Complex.
    Soldevila-Barreda JJ; Azmanova M; Pitto-Barry A; Cooper PA; Shnyder SD; Barry NPE
    ChemMedChem; 2020 Jun; 15(11):982-987. PubMed ID: 32237195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.